139
ИЛМИЙ-АМАЛИЙ ТИББИЁТ ЖУРНАЛИ, 2/2022
ТИББИЁТ ЯНГИЛИКЛАР, ИЛМИЙ МУШОХАДАЛАР
10. Collins R., MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart
disease. //British medical bulletin. — 1994. — Vol. 50. — P. 272-298.
11. Gu D., Reynolds K., Wu X., et al. Prevalence, Awareness, Treatment, and Control of Hypertension in China. //Hypertension.
— 2002. — Vol. 40. — P. 920-927.
12. Gupta R. Trends in hypertension epidemiology in India. //J. Hum. Hypertens. — 2004. — Vol. 18. — P. 73-78.
13. Gupta R., al-Odat N.A., Gupta V.P. Hypertension epidemiology in India: meta-analysis of 50 year prevalence rates and blood
pressure trends. //J. Hum. Hypertens. — 1996. — Vol. 10. — P. 465-472.
14. Hajjar I., Kotchen J.M., Kotchen T.A.
HYPERTENSION: Trends in Prevalence, Incidence and Control. //Annu. Rev. Public Health. — 2006. — Vol. 27. — P. 465-490.
15. Hajjar I., Kotchen T.
Trends in prevalence, awareness, treatment, and control of hypertension in the United States in 1988-
2000. //JAMA. — 2003. — Vol. 290. — P. 199-206.
16. Hoogen van den P., Feskens E., Nagelkerke N., et al. ^e relation between blood pressure and mortality due to coronary heart
disease among men in different parts of the world. //tte New Engl. J. of Med. — 2000. — Vol. 342. — P. 1-8.
17. Kearney P., Whelton M., Reynolds K., et al. Worldwide prevalence of hypertension: a systematic review. //J. of Hypertens.
— 2004. — Vol. 22. — P. 11-19.
18. Lawes C., Bennett D., Feigin V., et al. Blood Pressure and Stroke: An Overview of Published Reviews. //Stroke. — 2004. —
Vol. 35. — P. 1024-1033.
19. Mancia G., Backer de G., Dominiczak A., et al. 2007 Guidelines for the mangement of arterial hypertension. // Europan Heart
J. — 2007. — Vol. 28. — P. 1462-1536.
20. Mosterd A., DAgostino R.B., Silbershatz H., et al. Trends in the prevalence of hypertension, antihypertensive therapy, and left
ventricular hypertrophy from 1950 to 1989. //me New Engl. J. of Med. — 1999. — Vol. 340. — P. 1221-1227.
21. O’Brien E., Asmar R., Beilin L., et al. European Society of Hypertension recommendations for conventional, ambulatory and
home blood pressure measurement. //J. of Hypertens. — 2003. — Vol. 21. — P. 821-848.
22. Ong K.L., Cheung B., Man Y.B., et al. Prevalence, Awareness, Treatment, and Control of Hypertension Among United States
Adults 1999-2004. //Hypertension. — 2007. — Vol. 49. — P. 69-75.
23. Rashid P., Leonardi-Bee J., Bath P. Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular
Events: A Systematic Review. //Stroke. — 2003. — Vol. 34. — P. 2741-2748.
24. Staessen J.A., Fagard R., Wiijs L., et al. For the Systolic Hypertension in Europe (Syst-Eur) Trial investigators. Randomized
double-blind comparison of placebo and active treatment or older patients with isolated systolic hypertension. //Lancet. —
1997. — Vol. 350. — P. 757-764.
25. Wang Y., Wang Q.J. ^e Prevalence of Prehypertension and Hypertension Among US Adults According to the New Joint
National Committee Guidelines. //Arch. Intern. Med. — 2004. — Vol. 164. — P. 2126-2134.
26. Wolf-Maier K., Cooper R.S., Banegas J.R., et al. Hypertension prevalence and blood pressure levels in 6 European countries,
Canada and the United States. // JAMA. — 2003. — Vol. 289. — P. 2363-2369.
Do'stlaringiz bilan baham: